Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rook

Showing results (61-70 of 187) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|August 25, 1983
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndromeH C Lane, H Masur, L C Edgar, et al.
Blood|April 18, 2022
Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphomaSara Beygi, George E Duran, Sebastian Fernandez-Pol, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 20, 1999
Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cellsF E Fox, M Kubin, M Cassin, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanismsKaren S McGinnis, Jacqueline M Junkins-Hopkins, Glen Crawford, et al.
Cancer Research|March 26, 2009
In vivo imaging of cutaneous T-cell lymphoma migration to the skinChristoph Hoeller, Stephen K Richardson, Lai Guan Ng, et al.
Current Opinion in Oncology|April 29, 1998
Use of biological response modifiers in the treatment of cutaneous T-cell lymphomaA H Rook, E K Yoo, D J Grossman, et al.
Journal of the American Academy of Dermatology|December 1, 2009
Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphomaRachel H Gormley, Stephen D Hess, Dipti Anand, et al.
Journal of the American Academy of Dermatology|June 23, 2009
A novel regimen of vorinostat with interferon gamma for refractory Sézary syndromeJennifer M Gardner, Camille E Introcaso, Sunita D Nasta, et al.
Journal of the American Academy of Dermatology|February 15, 2011
Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides/Sézary syndromeKatherine G Evans, Andrea B Troxel, Barbara J DeNardo, et al.
Journal of the American Academy of Dermatology|October 5, 2010
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphomaYoun H Kim, Michael Girardi, Madeleine Duvic, et al.
Pageof 19

Showing results (61-70 of 187) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|August 25, 1983
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndromeH C Lane, H Masur, L C Edgar, et al.
Blood|April 18, 2022
Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphomaSara Beygi, George E Duran, Sebastian Fernandez-Pol, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 20, 1999
Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cellsF E Fox, M Kubin, M Cassin, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanismsKaren S McGinnis, Jacqueline M Junkins-Hopkins, Glen Crawford, et al.
Cancer Research|March 26, 2009
In vivo imaging of cutaneous T-cell lymphoma migration to the skinChristoph Hoeller, Stephen K Richardson, Lai Guan Ng, et al.
Current Opinion in Oncology|April 29, 1998
Use of biological response modifiers in the treatment of cutaneous T-cell lymphomaA H Rook, E K Yoo, D J Grossman, et al.
Journal of the American Academy of Dermatology|December 1, 2009
Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphomaRachel H Gormley, Stephen D Hess, Dipti Anand, et al.
Journal of the American Academy of Dermatology|June 23, 2009
A novel regimen of vorinostat with interferon gamma for refractory Sézary syndromeJennifer M Gardner, Camille E Introcaso, Sunita D Nasta, et al.
Journal of the American Academy of Dermatology|February 15, 2011
Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides/Sézary syndromeKatherine G Evans, Andrea B Troxel, Barbara J DeNardo, et al.
Journal of the American Academy of Dermatology|October 5, 2010
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphomaYoun H Kim, Michael Girardi, Madeleine Duvic, et al.
Pageof 19